Carl Walkey - May 19, 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Senior Vice President
Signature
/s/ Kris McGrew, as Attorney-in-Fact for Carl Walkey
Stock symbol
NLTX
Transactions as of
May 19, 2021
Transactions value $
-$6,378
Form type
4
Date filed
5/21/2021, 05:24 PM
Previous filing
May 12, 2021
Next filing
May 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NLTX Common Stock Sale -$6.38K -600 -0.04% $10.63 1.36M May 19, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 Includes 1,377 shares of Common Stock acquired on May 14, 2021 pursuant to the Issuer's employee stock purchase plan.